chronic back pain. Low back pain
Conditions
Interventions
Intervention 1: We injected 1 milligram Neostigmine in N group. Intervention 2: We injected 0.5 microgram in kilogram Dexmedetomidine in D group. Intervention 3: We injected 0.5 milligram Neostigmin
Treatment - Drugs
We injected 1 milligram Neostigmine in N group.
We injected 0.5 microgram in kilogram Dexmedetomidine in D group.
We injected 0.5 milligram Neostigmine and 0.5 microgram in kilogram Dexmedetomidine in ND group .
Sponsors
Ethics committee in Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Lumbar epidural block; 30-70 years; ASA I and II; lack of vitamin D Exclusion criteria: Allergy for this drug; failure in epidural block; history of fracture; lack of psychological disorders
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: every 5 minutes to recovery. Method of measurement: beat per minute.;Oxygen saturation. Timepoint: every 5 minutes to recovery. Method of measurement: percent.;Mean arterial pressure. Timepoint: every 5 minutes to recovery. Method of measurement: millimeter Hg.;Duration of analgesia. Timepoint: in recovery, one month and three months after block. Method of measurement: minute.;Pain. Timepoint: in recovery, one month and three months after block. Method of measurement: analog visual scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShima Zargar
Arak University Of Medical Sciences
Outcome results
None listed